Sunitinib causes dose-dependent negative functional effects on myocardium and cardiomyocytes

Arteriogenic Therapy by Intramyocardial Sustained Delivery of a Novel Growth Factor Combination Prevents Chronic Heart Failure

(2011) Sébastien Banquet et al.   CIRCULATION

Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors

(2011) Eric Raymond et al.   NEW ENGLAND JOURNAL OF MEDICINE

MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction

(2010) Benjamin Meder et al.   BASIC RESEARCH IN CARDIOLOGY

Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway

(2010) Takahiro Horie et al.   CARDIOVASCULAR RESEARCH

Circulating microRNAs are new and sensitive biomarkers of myocardial infarction

(2010) Yuri D'Alessandra et al.   EUROPEAN HEART JOURNAL

Cardiomyocyte PDGFR-β signaling is an essential component of the mouse cardiac response to load-induced stress

(2010) Vishnu Chintalgattu et al.   JOURNAL OF CLINICAL INVESTIGATION

Why do Kinase Inhibitors Cause Cardiotoxicity and What can be Done About It?

(2010) Hui Cheng et al.   PROGRESS IN CARDIOVASCULAR DISEASES

MicroRNAs and Ultraconserved Genes as Diagnostic Markers and Therapeutic Targets in Cancer and Cardiovascular Diseases

(2010) Julianna K. Edwards et al.   Journal of Cardiovascular Translational Research

Histopathology and biochemistry analysis of the interaction between sunitinib and paracetamol in mice

(2010) Adeline YL Lim et al.   BMC Pharmacology & Toxicology

Pharmacokinetics of sunitinib in an obese patient with a GIST

(2009) I. M. E. Desar et al.   ANNALS OF ONCOLOGY

Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis

(2009) G. Di Lorenzo et al.   ANNALS OF ONCOLOGY

Plasma miR-208 as a Biomarker of Myocardial Injury

(2009) X. Ji et al.   CLINICAL CHEMISTRY

Sunitinib-Induced Cardiotoxicity Is Mediated by Off-Target Inhibition of AMP-Activated Protein Kinase

(2009) Risto Kerkela et al.   CTS-Clinical and Translational Science

MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice

(2009) Thomas E. Callis et al.   JOURNAL OF CLINICAL INVESTIGATION

MicroRNA-1 Negatively Regulates Expression of the Hypertrophy-Associated Calmodulin and Mef2a Genes

(2009) S. Ikeda et al.   MOLECULAR AND CELLULAR BIOLOGY

miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy

(2009) Z. Lin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate

(2008) M. L. Telli et al.   ANNALS OF ONCOLOGY

Relationship of imatinib-free plasma levels and target genotype with efficacy and tolerability

(2008) N Widmer et al.   BRITISH JOURNAL OF CANCER

Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma

(2008) Manuela Schmidinger et al.   JOURNAL OF CLINICAL ONCOLOGY

Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor

(2008) Michael C. Heinrich et al.   JOURNAL OF CLINICAL ONCOLOGY

miRNA expression in the failing human heart: Functional correlates

(2008) Carmen Sucharov et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Mechanisms of Myocyte Cytotoxicity Induced by the Multiple Receptor Tyrosine Kinase Inhibitor Sunitinib

(2008) B. B. Hasinoff et al.   MOLECULAR PHARMACOLOGY